Biora Therapeutics Inc (BIOR) Gross Profit Margin starting from the second quarter 2026 to second quarter 2023, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Biora Therapeutics Inc   (NASDAQ: BIOR)


Biora Therapeutics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BIOR Gross Profit Margin (Jun 30 2026)
Q2 		(Sep 30 2024)
Q3 		(Jun 30 2024)
Q2 		(Mar 31 2024)
Q1 		(Dec 31 2023)
Q4
Y / Y Revenue Change -
Seq. Revenue Change 9946.85 %
Revenue In Millions $3.21
Gross Profit Margin 6.27 %
Gross Profit Margin Total Ranking #
Gross Profit In Millions $0.20
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Second Quarter 2026 Gross Profit Margin
Biora Therapeutics Inc achieved Gross Profit of $0 millions compare to Gross Loss of $0.00 millions recorded in the previous quarter. Revenue increased by 9946.85 % Company accomplished below the average Gross Profit Margin with 6.27 %.


Observing second quarter 2026 results within Major Pharmaceutical Preparations industry Biora Therapeutics Inc has achieved highest Gross Profit Margin. While overall Gross Profit Margin ranking remained unchanged compared to the previous quarter at no. .
Learn about Gross Margin
BIOR's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Gross Profit Margin Statistics
High Average Low
93.15 % 47.43 % 0.74 %
(Jun 30 2012)   (Dec 31 2020)


BIOR Gross Income Trends • More of BIOR's Profitabilty Ratios • BIOR Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
BIOR's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
BIOR's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for BIOR's Competitors
Gross Profit Margin Profit Margin for Biora Therapeutics Inc 's Suppliers
Gross Profit Margin Profit Margin for BIOR's Customers

You may also want to know
BIOR's Annual Growth Rates BIOR's Profitability Ratios BIOR's Asset Turnover Ratio BIOR's Dividend Growth
BIOR's Roe BIOR's Valuation Ratios BIOR's Financial Strength Ratios BIOR's Gross Profit Growth
BIOR's Roa BIOR's Inventory Turnover Ratio BIOR's Growth Rates BIOR's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue
Jaguar Health Inc   15.84 %$ 0.194  Millions$ 1.225  Millions
Hcw Biologics Inc   10.82 %$ 0.028  Millions$ 0.257  Millions
China Pharma Holdings Inc  8.81 %$ 0.084  Millions$ 0.948  Millions
Lftd Partners Inc   7.48 %$ 0.651  Millions$ 8.705  Millions
Biora Therapeutics Inc   6.27 %$ 0.202  Millions$ 3.215  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.